| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apoptosis | 91 | 2022 | 2377 | 7.160 |
Why?
|
| Phagocytosis | 94 | 2017 | 356 | 6.310 |
Why?
|
| Macrophages | 94 | 2023 | 1281 | 5.820 |
Why?
|
| Neutrophils | 167 | 2022 | 1170 | 5.550 |
Why?
|
| Phosphatidylserines | 28 | 2013 | 87 | 2.770 |
Why?
|
| Lung | 87 | 2022 | 3685 | 2.220 |
Why?
|
| Platelet Activating Factor | 34 | 2008 | 87 | 1.850 |
Why?
|
| Phagocytes | 19 | 2017 | 91 | 1.810 |
Why?
|
| Macrophages, Alveolar | 23 | 2021 | 357 | 1.680 |
Why?
|
| Receptors, Cell Surface | 22 | 2020 | 358 | 1.680 |
Why?
|
| Transforming Growth Factor beta | 18 | 2014 | 447 | 1.670 |
Why?
|
| Inflammation | 57 | 2023 | 2503 | 1.610 |
Why?
|
| Animals | 284 | 2022 | 32123 | 1.600 |
Why?
|
| Inflammation Mediators | 8 | 2015 | 481 | 1.550 |
Why?
|
| Monocytes | 34 | 2023 | 504 | 1.510 |
Why?
|
| Complement C5 | 45 | 2000 | 74 | 1.390 |
Why?
|
| Blood Platelets | 49 | 1998 | 350 | 1.320 |
Why?
|
| Dendritic Cells | 14 | 2018 | 436 | 1.280 |
Why?
|
| Mice | 127 | 2022 | 15075 | 1.230 |
Why?
|
| Chemotaxis, Leukocyte | 28 | 2006 | 130 | 1.190 |
Why?
|
| Oxidants | 7 | 2014 | 113 | 1.090 |
Why?
|
| Pulmonary Alveoli | 22 | 2021 | 376 | 1.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 10 | 2022 | 1115 | 0.990 |
Why?
|
| Chemotactic Factors | 14 | 2009 | 47 | 0.980 |
Why?
|
| Epithelial Cells | 9 | 2017 | 965 | 0.940 |
Why?
|
| Tumor Necrosis Factor-alpha | 19 | 2014 | 1138 | 0.940 |
Why?
|
| Mitogen-Activated Protein Kinases | 12 | 2010 | 277 | 0.930 |
Why?
|
| Granulomatous Disease, Chronic | 9 | 2022 | 60 | 0.900 |
Why?
|
| Cells, Cultured | 56 | 2018 | 3916 | 0.890 |
Why?
|
| Lipopolysaccharides | 32 | 2023 | 832 | 0.890 |
Why?
|
| Signal Transduction | 34 | 2022 | 4526 | 0.860 |
Why?
|
| Respiratory Mucosa | 5 | 2013 | 261 | 0.830 |
Why?
|
| Fibroblasts | 10 | 2014 | 838 | 0.790 |
Why?
|
| Receptors, G-Protein-Coupled | 9 | 2016 | 193 | 0.770 |
Why?
|
| Rabbits | 87 | 1999 | 755 | 0.770 |
Why?
|
| Pneumonia | 22 | 2023 | 576 | 0.760 |
Why?
|
| Receptors, Immunologic | 6 | 2019 | 201 | 0.750 |
Why?
|
| Lung Injury | 6 | 2018 | 201 | 0.750 |
Why?
|
| MAP Kinase Signaling System | 4 | 2013 | 274 | 0.720 |
Why?
|
| Cytophagocytosis | 3 | 2022 | 10 | 0.720 |
Why?
|
| Mammary Glands, Animal | 4 | 2015 | 116 | 0.720 |
Why?
|
| Pulmonary Fibrosis | 10 | 2018 | 331 | 0.700 |
Why?
|
| CD36 Antigens | 5 | 2013 | 38 | 0.690 |
Why?
|
| Macrophages, Peritoneal | 8 | 2011 | 93 | 0.690 |
Why?
|
| Humans | 219 | 2023 | 115908 | 0.690 |
Why?
|
| Antigen Presentation | 4 | 2017 | 189 | 0.670 |
Why?
|
| Jurkat Cells | 20 | 2012 | 130 | 0.660 |
Why?
|
| Mice, Inbred C57BL | 46 | 2022 | 4769 | 0.640 |
Why?
|
| Arachidonic Acid | 19 | 2011 | 118 | 0.640 |
Why?
|
| Acute Lung Injury | 4 | 2017 | 302 | 0.630 |
Why?
|
| src-Family Kinases | 2 | 2013 | 87 | 0.620 |
Why?
|
| Calreticulin | 4 | 2006 | 23 | 0.610 |
Why?
|
| Dinoprostone | 10 | 2013 | 188 | 0.600 |
Why?
|
| Lactation | 2 | 2009 | 149 | 0.590 |
Why?
|
| rac1 GTP-Binding Protein | 4 | 2013 | 57 | 0.590 |
Why?
|
| Membrane Lipids | 8 | 2005 | 87 | 0.580 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2017 | 609 | 0.560 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 2000 | 171 | 0.550 |
Why?
|
| Flow Cytometry | 14 | 2018 | 1059 | 0.540 |
Why?
|
| Cell Communication | 10 | 2017 | 281 | 0.530 |
Why?
|
| Lysosomes | 18 | 1994 | 126 | 0.530 |
Why?
|
| Membrane Glycoproteins | 11 | 2019 | 429 | 0.530 |
Why?
|
| Phospholipids | 8 | 2011 | 202 | 0.520 |
Why?
|
| Pulmonary Emphysema | 2 | 2022 | 318 | 0.520 |
Why?
|
| Myeloid Cells | 1 | 2016 | 127 | 0.510 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 2598 | 0.510 |
Why?
|
| Collagen | 7 | 2012 | 415 | 0.500 |
Why?
|
| Complement C3 | 11 | 2011 | 191 | 0.500 |
Why?
|
| Mice, Knockout | 23 | 2022 | 2606 | 0.500 |
Why?
|
| In Vitro Techniques | 34 | 2006 | 1044 | 0.490 |
Why?
|
| Cytoplasmic Granules | 18 | 1994 | 82 | 0.490 |
Why?
|
| NADPH Oxidases | 8 | 2022 | 123 | 0.490 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2016 | 222 | 0.480 |
Why?
|
| Cell Adhesion | 21 | 2000 | 433 | 0.480 |
Why?
|
| Membrane Proteins | 12 | 2008 | 1033 | 0.470 |
Why?
|
| fas Receptor | 4 | 2014 | 93 | 0.470 |
Why?
|
| Caenorhabditis elegans Proteins | 6 | 2006 | 180 | 0.460 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2013 | 19 | 0.450 |
Why?
|
| Bronchi | 6 | 2006 | 253 | 0.450 |
Why?
|
| Eicosanoids | 4 | 2006 | 56 | 0.450 |
Why?
|
| Pinocytosis | 5 | 2009 | 10 | 0.450 |
Why?
|
| Mitochondria | 7 | 2015 | 753 | 0.450 |
Why?
|
| rho GTP-Binding Proteins | 4 | 2010 | 62 | 0.440 |
Why?
|
| Leukotrienes | 8 | 2008 | 35 | 0.430 |
Why?
|
| Immunoglobulin G | 17 | 2011 | 782 | 0.430 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2013 | 155 | 0.430 |
Why?
|
| Cell Movement | 21 | 2016 | 868 | 0.420 |
Why?
|
| Antigens, Differentiation | 5 | 2008 | 79 | 0.420 |
Why?
|
| Receptors, IgG | 4 | 2009 | 66 | 0.420 |
Why?
|
| Mice, Transgenic | 16 | 2022 | 1970 | 0.420 |
Why?
|
| Oligopeptides | 11 | 2006 | 248 | 0.420 |
Why?
|
| Models, Biological | 16 | 2013 | 1647 | 0.420 |
Why?
|
| Collectins | 4 | 2006 | 12 | 0.410 |
Why?
|
| Antigens, Surface | 5 | 2006 | 151 | 0.410 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 22 | 2008 | 64 | 0.410 |
Why?
|
| Lymphatic Vessels | 1 | 2012 | 54 | 0.410 |
Why?
|
| Antibodies, Monoclonal | 16 | 2012 | 1262 | 0.410 |
Why?
|
| Homeostasis | 5 | 2017 | 576 | 0.400 |
Why?
|
| Hypersensitivity | 3 | 2013 | 272 | 0.400 |
Why?
|
| Platelet Membrane Glycoproteins | 5 | 1995 | 37 | 0.400 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2013 | 356 | 0.390 |
Why?
|
| Bronchoalveolar Lavage Fluid | 16 | 2021 | 609 | 0.390 |
Why?
|
| Cell Differentiation | 16 | 2017 | 1707 | 0.390 |
Why?
|
| Carrier Proteins | 6 | 2004 | 703 | 0.390 |
Why?
|
| Protein Biosynthesis | 5 | 2008 | 389 | 0.380 |
Why?
|
| Zymosan | 25 | 2010 | 63 | 0.380 |
Why?
|
| Sequence Analysis, RNA | 4 | 2023 | 389 | 0.380 |
Why?
|
| Lung Diseases, Interstitial | 4 | 2012 | 520 | 0.370 |
Why?
|
| Cytokines | 11 | 2014 | 1857 | 0.370 |
Why?
|
| Interleukin-8 | 4 | 2009 | 243 | 0.370 |
Why?
|
| Lymph Nodes | 6 | 2016 | 422 | 0.360 |
Why?
|
| Bleomycin | 10 | 2018 | 232 | 0.360 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2009 | 175 | 0.360 |
Why?
|
| Regeneration | 2 | 2014 | 162 | 0.360 |
Why?
|
| Kinetics | 33 | 2008 | 1560 | 0.350 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2010 | 25 | 0.350 |
Why?
|
| Histological Techniques | 1 | 2010 | 40 | 0.350 |
Why?
|
| Cigarette Smoking | 2 | 2022 | 80 | 0.350 |
Why?
|
| rhoA GTP-Binding Protein | 7 | 2010 | 75 | 0.350 |
Why?
|
| Gamma Rays | 1 | 2010 | 47 | 0.350 |
Why?
|
| Whole-Body Irradiation | 1 | 2010 | 72 | 0.350 |
Why?
|
| SRS-A | 14 | 1992 | 28 | 0.350 |
Why?
|
| Bone Marrow Transplantation | 3 | 2010 | 241 | 0.350 |
Why?
|
| Basophils | 16 | 1988 | 64 | 0.350 |
Why?
|
| Repressor Proteins | 4 | 2016 | 369 | 0.340 |
Why?
|
| Complement System Proteins | 24 | 1987 | 288 | 0.340 |
Why?
|
| Cell Cycle Proteins | 5 | 2016 | 555 | 0.340 |
Why?
|
| Endothelium, Vascular | 9 | 2007 | 845 | 0.340 |
Why?
|
| Cell Line | 16 | 2012 | 2655 | 0.340 |
Why?
|
| Disease Models, Animal | 19 | 2022 | 3582 | 0.340 |
Why?
|
| Cell Membrane | 18 | 2013 | 682 | 0.340 |
Why?
|
| CD47 Antigen | 2 | 2006 | 21 | 0.340 |
Why?
|
| Blotting, Western | 8 | 2013 | 1153 | 0.340 |
Why?
|
| Nitric Oxide | 4 | 2012 | 834 | 0.330 |
Why?
|
| Complement C5a | 18 | 1997 | 59 | 0.330 |
Why?
|
| Reperfusion Injury | 1 | 2011 | 257 | 0.330 |
Why?
|
| Phagosomes | 3 | 2012 | 39 | 0.320 |
Why?
|
| Interferon-gamma | 5 | 2016 | 731 | 0.320 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 1318 | 0.320 |
Why?
|
| Caenorhabditis elegans | 5 | 2005 | 271 | 0.320 |
Why?
|
| Endopeptidases | 4 | 2003 | 72 | 0.320 |
Why?
|
| Thiazolidinediones | 3 | 2015 | 143 | 0.320 |
Why?
|
| Endotoxins | 7 | 1989 | 208 | 0.320 |
Why?
|
| Cytoskeletal Proteins | 2 | 2006 | 145 | 0.320 |
Why?
|
| Capillary Permeability | 15 | 1992 | 138 | 0.320 |
Why?
|
| Complement C1q | 4 | 2006 | 38 | 0.310 |
Why?
|
| Immunity, Innate | 7 | 2017 | 734 | 0.310 |
Why?
|
| Immunotherapy | 2 | 2011 | 480 | 0.310 |
Why?
|
| Phospholipases A | 3 | 2007 | 101 | 0.300 |
Why?
|
| Integrins | 4 | 2006 | 79 | 0.300 |
Why?
|
| Pulmonary Circulation | 13 | 1997 | 408 | 0.300 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2018 | 686 | 0.300 |
Why?
|
| Leukocyte Elastase | 3 | 2002 | 79 | 0.290 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 6 | 2010 | 59 | 0.290 |
Why?
|
| Cell Fractionation | 3 | 2001 | 53 | 0.290 |
Why?
|
| Lysophospholipids | 5 | 2013 | 65 | 0.290 |
Why?
|
| Alveolar Epithelial Cells | 2 | 2018 | 100 | 0.290 |
Why?
|
| Emphysema | 3 | 2012 | 124 | 0.290 |
Why?
|
| Macrophage-1 Antigen | 4 | 2006 | 33 | 0.280 |
Why?
|
| Cystic Fibrosis | 6 | 2006 | 961 | 0.280 |
Why?
|
| Antigens, CD | 7 | 2014 | 443 | 0.280 |
Why?
|
| Proteins | 6 | 2004 | 922 | 0.280 |
Why?
|
| Enzyme Activation | 16 | 2010 | 791 | 0.280 |
Why?
|
| Adaptive Immunity | 2 | 2018 | 157 | 0.280 |
Why?
|
| Intracellular Fluid | 1 | 2006 | 26 | 0.280 |
Why?
|
| Microscopy, Electron | 26 | 2007 | 406 | 0.280 |
Why?
|
| Male | 83 | 2022 | 56128 | 0.280 |
Why?
|
| Mice, Inbred C3H | 15 | 2001 | 244 | 0.270 |
Why?
|
| Chemotaxis | 12 | 2009 | 132 | 0.270 |
Why?
|
| Female | 69 | 2022 | 60086 | 0.270 |
Why?
|
| Autoimmunity | 4 | 2007 | 823 | 0.270 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 288 | 0.270 |
Why?
|
| Receptors, Vitronectin | 4 | 2006 | 8 | 0.270 |
Why?
|
| Platelet Aggregation | 10 | 2006 | 94 | 0.270 |
Why?
|
| beta-Glucans | 5 | 1993 | 19 | 0.260 |
Why?
|
| rac GTP-Binding Proteins | 2 | 2005 | 34 | 0.260 |
Why?
|
| Receptors, Complement | 7 | 2006 | 112 | 0.260 |
Why?
|
| Immunoglobulin E | 10 | 1982 | 363 | 0.260 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2017 | 225 | 0.260 |
Why?
|
| Phosphoserine | 2 | 2004 | 33 | 0.260 |
Why?
|
| Phospholipid Transfer Proteins | 3 | 2004 | 11 | 0.260 |
Why?
|
| Mammals | 2 | 2005 | 251 | 0.250 |
Why?
|
| Leukocytes | 13 | 2022 | 284 | 0.250 |
Why?
|
| Bronchiectasis | 2 | 2006 | 108 | 0.250 |
Why?
|
| Serotonin | 19 | 1990 | 296 | 0.250 |
Why?
|
| Zinc Fingers | 1 | 2004 | 45 | 0.240 |
Why?
|
| Endothelium | 8 | 2014 | 115 | 0.240 |
Why?
|
| Bone Marrow Cells | 11 | 2017 | 272 | 0.240 |
Why?
|
| Gene Expression Regulation | 7 | 2019 | 2362 | 0.240 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 1548 | 0.240 |
Why?
|
| Interleukin-12 | 1 | 2004 | 110 | 0.230 |
Why?
|
| Lung Diseases | 9 | 1994 | 710 | 0.230 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2016 | 28 | 0.230 |
Why?
|
| Lectins | 3 | 2001 | 47 | 0.230 |
Why?
|
| Glycoproteins | 4 | 2013 | 308 | 0.230 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2003 | 3 | 0.230 |
Why?
|
| Autoantibodies | 2 | 2011 | 1362 | 0.230 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 341 | 0.230 |
Why?
|
| Peptides | 8 | 2013 | 862 | 0.220 |
Why?
|
| Time Factors | 32 | 2014 | 6186 | 0.220 |
Why?
|
| Arachidonate 5-Lipoxygenase | 6 | 2008 | 45 | 0.220 |
Why?
|
| Folate Receptor 2 | 1 | 2023 | 6 | 0.220 |
Why?
|
| Complement Activation | 8 | 2006 | 343 | 0.220 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2012 | 504 | 0.220 |
Why?
|
| Calcium | 12 | 1997 | 1102 | 0.220 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2013 | 794 | 0.220 |
Why?
|
| Macrophage Activation | 8 | 2012 | 164 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 213 | 0.210 |
Why?
|
| Antigen-Antibody Complex | 15 | 1983 | 88 | 0.210 |
Why?
|
| Extracellular Matrix | 2 | 2006 | 439 | 0.210 |
Why?
|
| Antigens | 11 | 2013 | 322 | 0.210 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 5 | 2011 | 59 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 7 | 2004 | 262 | 0.210 |
Why?
|
| Bone Marrow | 3 | 1993 | 248 | 0.200 |
Why?
|
| Cyclic AMP | 3 | 2011 | 227 | 0.200 |
Why?
|
| Cell Count | 6 | 2020 | 304 | 0.200 |
Why?
|
| Lysophosphatidylcholines | 5 | 1988 | 30 | 0.200 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 4 | 2008 | 32 | 0.200 |
Why?
|
| Respiratory System | 2 | 2005 | 141 | 0.200 |
Why?
|
| Polyamines | 1 | 2022 | 39 | 0.200 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 54 | 0.190 |
Why?
|
| Isoenzymes | 3 | 2000 | 286 | 0.190 |
Why?
|
| Pseudomonas Infections | 4 | 1996 | 190 | 0.190 |
Why?
|
| Cytochalasin B | 9 | 1994 | 17 | 0.190 |
Why?
|
| Gene Deletion | 4 | 2018 | 356 | 0.190 |
Why?
|
| Trachea | 5 | 2007 | 234 | 0.190 |
Why?
|
| Calcimycin | 12 | 2008 | 46 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 538 | 0.190 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 6 | 2009 | 139 | 0.190 |
Why?
|
| Ribonucleoproteins | 1 | 2001 | 87 | 0.190 |
Why?
|
| c-Mer Tyrosine Kinase | 3 | 2017 | 43 | 0.190 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 3 | 2016 | 39 | 0.180 |
Why?
|
| Listeriosis | 4 | 2012 | 60 | 0.180 |
Why?
|
| Lipid Metabolism | 3 | 2011 | 449 | 0.180 |
Why?
|
| Eosinophils | 6 | 2003 | 283 | 0.180 |
Why?
|
| Complement C3a | 1 | 2000 | 33 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 1999 | 113 | 0.180 |
Why?
|
| Fas Ligand Protein | 2 | 2014 | 57 | 0.180 |
Why?
|
| Blood Vessels | 6 | 2011 | 181 | 0.180 |
Why?
|
| Superoxides | 9 | 2014 | 215 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 1 | 2001 | 206 | 0.180 |
Why?
|
| Biogenic Polyamines | 1 | 1999 | 1 | 0.170 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2003 | 146 | 0.170 |
Why?
|
| Immunoglobulin M | 3 | 2018 | 251 | 0.170 |
Why?
|
| Interleukin-4 | 3 | 2008 | 212 | 0.170 |
Why?
|
| Up-Regulation | 4 | 2010 | 824 | 0.170 |
Why?
|
| Glucans | 6 | 1995 | 25 | 0.170 |
Why?
|
| Pancreatic Elastase | 4 | 1988 | 67 | 0.170 |
Why?
|
| Endocytosis | 4 | 2011 | 152 | 0.170 |
Why?
|
| Erythrocytes | 9 | 2009 | 590 | 0.170 |
Why?
|
| NADPH Oxidase 2 | 5 | 2014 | 42 | 0.170 |
Why?
|
| Hydrolases | 4 | 1993 | 52 | 0.170 |
Why?
|
| Plants, Medicinal | 1 | 1999 | 19 | 0.170 |
Why?
|
| NF-kappa B | 5 | 2006 | 639 | 0.160 |
Why?
|
| Toll-Like Receptors | 2 | 2012 | 166 | 0.160 |
Why?
|
| Antigens, Ly | 2 | 2016 | 45 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 10 | 2009 | 1165 | 0.160 |
Why?
|
| Mononuclear Phagocyte System | 2 | 2016 | 14 | 0.160 |
Why?
|
| Protein Binding | 10 | 2010 | 1919 | 0.160 |
Why?
|
| Graft Rejection | 2 | 2015 | 533 | 0.160 |
Why?
|
| Leukotriene B4 | 5 | 2003 | 48 | 0.160 |
Why?
|
| Prostaglandin D2 | 2 | 1997 | 21 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 503 | 0.160 |
Why?
|
| Cell Survival | 8 | 2009 | 1026 | 0.150 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2018 | 20 | 0.150 |
Why?
|
| Blood Coagulation Factors | 6 | 1981 | 44 | 0.150 |
Why?
|
| Antibodies | 11 | 2010 | 374 | 0.150 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 3 | 2008 | 25 | 0.150 |
Why?
|
| CD11 Antigens | 1 | 2018 | 31 | 0.150 |
Why?
|
| Glucuronidase | 18 | 1993 | 42 | 0.150 |
Why?
|
| Peritonitis | 4 | 2013 | 76 | 0.150 |
Why?
|
| Membrane Transport Proteins | 1 | 1998 | 137 | 0.150 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1870 | 0.150 |
Why?
|
| Milk | 2 | 2009 | 124 | 0.150 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 31 | 0.150 |
Why?
|
| Reactive Oxygen Species | 4 | 2015 | 552 | 0.150 |
Why?
|
| RNA, Messenger | 11 | 2013 | 2581 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2022 | 332 | 0.150 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 118 | 0.150 |
Why?
|
| Lymphocyte Activation | 5 | 2018 | 1056 | 0.150 |
Why?
|
| Oxidative Stress | 4 | 2009 | 1096 | 0.140 |
Why?
|
| Neutrophil Activation | 4 | 2008 | 93 | 0.140 |
Why?
|
| Plant Extracts | 1 | 1999 | 153 | 0.140 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 224 | 0.140 |
Why?
|
| Lipid Bilayers | 4 | 2000 | 100 | 0.140 |
Why?
|
| Intracellular Space | 1 | 2017 | 68 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 1995 | 281 | 0.140 |
Why?
|
| Microcirculation | 13 | 2007 | 138 | 0.140 |
Why?
|
| Cattle | 8 | 2009 | 935 | 0.140 |
Why?
|
| Lymphocytes | 3 | 2001 | 342 | 0.140 |
Why?
|
| Receptors, Cytoadhesin | 2 | 1994 | 2 | 0.140 |
Why?
|
| Transplantation, Homologous | 4 | 2015 | 398 | 0.140 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 58 | 0.140 |
Why?
|
| PPAR gamma | 3 | 2015 | 185 | 0.140 |
Why?
|
| Phosphorylation | 4 | 2009 | 1561 | 0.140 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 53 | 0.140 |
Why?
|
| Listeria monocytogenes | 6 | 2012 | 110 | 0.140 |
Why?
|
| Liposomes | 4 | 2005 | 149 | 0.140 |
Why?
|
| Arachidonic Acids | 10 | 1989 | 58 | 0.140 |
Why?
|
| Disease | 1 | 2017 | 83 | 0.140 |
Why?
|
| Drosophila melanogaster | 3 | 2004 | 190 | 0.140 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 4 | 2006 | 14 | 0.130 |
Why?
|
| Intracellular Membranes | 3 | 2003 | 73 | 0.130 |
Why?
|
| Muramidase | 13 | 1999 | 73 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2010 | 1868 | 0.130 |
Why?
|
| Spleen | 9 | 2016 | 491 | 0.130 |
Why?
|
| Monensin | 2 | 1994 | 6 | 0.130 |
Why?
|
| Enzyme Inhibitors | 6 | 2004 | 758 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2013 | 88 | 0.130 |
Why?
|
| Growth Substances | 4 | 2004 | 136 | 0.130 |
Why?
|
| Integrin alpha Chains | 2 | 2014 | 22 | 0.130 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2015 | 8 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 3 | 2013 | 165 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2019 | 160 | 0.130 |
Why?
|
| Peroxidase | 8 | 1999 | 157 | 0.130 |
Why?
|
| Asthma | 8 | 2013 | 2152 | 0.130 |
Why?
|
| 3T3 Cells | 2 | 2008 | 137 | 0.130 |
Why?
|
| Leukocyte Common Antigens | 2 | 2013 | 75 | 0.130 |
Why?
|
| Anaphylatoxins | 5 | 1981 | 6 | 0.130 |
Why?
|
| Adherens Junctions | 1 | 2015 | 26 | 0.130 |
Why?
|
| Serum Albumin | 4 | 1990 | 135 | 0.130 |
Why?
|
| Oxygen | 8 | 2001 | 839 | 0.130 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2015 | 41 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2018 | 965 | 0.130 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2006 | 63 | 0.130 |
Why?
|
| Histamine Release | 10 | 1988 | 22 | 0.120 |
Why?
|
| Skin Transplantation | 1 | 2015 | 58 | 0.120 |
Why?
|
| Protein Kinases | 1 | 1997 | 306 | 0.120 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 7 | 2003 | 40 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1999 | 394 | 0.120 |
Why?
|
| T-Lymphocytes | 6 | 2007 | 1758 | 0.120 |
Why?
|
| Mice, Inbred ICR | 5 | 2009 | 111 | 0.120 |
Why?
|
| Necrosis | 2 | 2008 | 211 | 0.120 |
Why?
|
| Exocytosis | 6 | 1984 | 89 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 934 | 0.120 |
Why?
|
| AC133 Antigen | 1 | 2013 | 20 | 0.120 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2014 | 23 | 0.120 |
Why?
|
| Esterases | 6 | 1985 | 12 | 0.120 |
Why?
|
| Middle Aged | 10 | 2021 | 27084 | 0.120 |
Why?
|
| Muscle, Smooth | 4 | 1992 | 149 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2006 | 147 | 0.110 |
Why?
|
| Vasodilation | 5 | 1991 | 413 | 0.110 |
Why?
|
| Colony-Forming Units Assay | 1 | 2013 | 92 | 0.110 |
Why?
|
| Colitis | 1 | 2016 | 226 | 0.110 |
Why?
|
| beta Catenin | 2 | 2015 | 220 | 0.110 |
Why?
|
| Phospholipid Ethers | 3 | 1991 | 7 | 0.110 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 97 | 0.110 |
Why?
|
| Antioxidants | 3 | 2007 | 533 | 0.110 |
Why?
|
| Complement C3b | 3 | 1989 | 30 | 0.110 |
Why?
|
| Arthritis | 5 | 1989 | 110 | 0.110 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 396 | 0.110 |
Why?
|
| Leukotriene C4 | 4 | 2000 | 12 | 0.110 |
Why?
|
| Ethanol | 3 | 2010 | 549 | 0.110 |
Why?
|
| Chlorides | 1 | 1994 | 130 | 0.110 |
Why?
|
| Leukocyte Disorders | 1 | 2013 | 11 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2010 | 399 | 0.110 |
Why?
|
| Chemokines | 4 | 2004 | 214 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2012 | 12 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 174 | 0.110 |
Why?
|
| Prostaglandins | 4 | 1987 | 78 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2012 | 16 | 0.110 |
Why?
|
| Lymphangiogenesis | 1 | 2012 | 24 | 0.110 |
Why?
|
| Vital Capacity | 1 | 2013 | 279 | 0.110 |
Why?
|
| Cell Separation | 8 | 2011 | 293 | 0.110 |
Why?
|
| RNA | 3 | 2016 | 821 | 0.110 |
Why?
|
| Opsonin Proteins | 4 | 2006 | 25 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 1643 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 319 | 0.100 |
Why?
|
| Disease Progression | 3 | 2009 | 2424 | 0.100 |
Why?
|
| Hydrogen Peroxide | 5 | 2007 | 286 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2006 | 123 | 0.100 |
Why?
|
| CD40 Ligand | 2 | 2018 | 42 | 0.100 |
Why?
|
| Muscle Contraction | 5 | 1992 | 398 | 0.100 |
Why?
|
| Lipids | 3 | 2013 | 589 | 0.100 |
Why?
|
| Nigericin | 1 | 1991 | 2 | 0.100 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 522 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2006 | 513 | 0.100 |
Why?
|
| Aged | 7 | 2020 | 19299 | 0.100 |
Why?
|
| Cathepsin G | 2 | 2002 | 6 | 0.100 |
Why?
|
| Cathepsins | 2 | 2002 | 22 | 0.100 |
Why?
|
| Neutrophil Infiltration | 2 | 2010 | 95 | 0.100 |
Why?
|
| Stress, Mechanical | 2 | 1998 | 440 | 0.100 |
Why?
|
| Mucin-5B | 1 | 2013 | 185 | 0.100 |
Why?
|
| Mice, Inbred Strains | 8 | 2007 | 399 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 68 | 0.100 |
Why?
|
| Caspase 8 | 1 | 2011 | 43 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2017 | 2196 | 0.100 |
Why?
|
| Adult | 19 | 2021 | 30820 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2010 | 804 | 0.100 |
Why?
|
| Anaphylaxis | 4 | 1977 | 148 | 0.100 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2011 | 29 | 0.100 |
Why?
|
| Therapeutic Irrigation | 10 | 1993 | 65 | 0.100 |
Why?
|
| Sphingomyelins | 1 | 2011 | 28 | 0.100 |
Why?
|
| Leukotriene A4 | 3 | 1999 | 11 | 0.100 |
Why?
|
| Rats | 20 | 2004 | 5035 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2017 | 610 | 0.100 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2009 | 34 | 0.100 |
Why?
|
| Serine Endopeptidases | 2 | 2002 | 102 | 0.090 |
Why?
|
| Mast Cells | 5 | 1988 | 118 | 0.090 |
Why?
|
| Adenosine Triphosphate | 6 | 2009 | 430 | 0.090 |
Why?
|
| Granulocytes | 3 | 2000 | 78 | 0.090 |
Why?
|
| Adoptive Transfer | 4 | 2015 | 200 | 0.090 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 33 | 0.090 |
Why?
|
| HL-60 Cells | 3 | 2001 | 27 | 0.090 |
Why?
|
| Amiloride | 2 | 2009 | 23 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2009 | 73 | 0.090 |
Why?
|
| Erythrocyte Membrane | 1 | 1991 | 50 | 0.090 |
Why?
|
| CD18 Antigens | 3 | 2000 | 33 | 0.090 |
Why?
|
| Actins | 3 | 2009 | 385 | 0.090 |
Why?
|
| Healthy Volunteers | 2 | 2022 | 191 | 0.090 |
Why?
|
| DNA Fragmentation | 2 | 2008 | 47 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2020 | 3054 | 0.090 |
Why?
|
| Immune Sera | 8 | 2005 | 80 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2014 | 260 | 0.090 |
Why?
|
| Epithelium | 4 | 2017 | 297 | 0.090 |
Why?
|
| Radiation Chimera | 1 | 2010 | 31 | 0.090 |
Why?
|
| Parasympathetic Nervous System | 2 | 1992 | 25 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 796 | 0.090 |
Why?
|
| Hypersensitivity, Immediate | 2 | 1985 | 57 | 0.090 |
Why?
|
| Lipopolysaccharide Receptors | 3 | 2019 | 85 | 0.090 |
Why?
|
| Radiography | 1 | 2012 | 826 | 0.090 |
Why?
|
| Uridine Triphosphate | 1 | 2009 | 11 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2003 | 376 | 0.090 |
Why?
|
| Anemia | 1 | 2011 | 144 | 0.090 |
Why?
|
| Ultraviolet Rays | 3 | 2016 | 373 | 0.090 |
Why?
|
| Stress Fibers | 1 | 2009 | 16 | 0.090 |
Why?
|
| Blood Cells | 1 | 1989 | 39 | 0.090 |
Why?
|
| Leukocyte Count | 10 | 2000 | 295 | 0.080 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2005 | 34 | 0.080 |
Why?
|
| Drug Synergism | 3 | 1997 | 316 | 0.080 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2009 | 9 | 0.080 |
Why?
|
| L-Lactate Dehydrogenase | 12 | 1986 | 107 | 0.080 |
Why?
|
| Biopsy | 1 | 2012 | 1056 | 0.080 |
Why?
|
| Arachidonate 15-Lipoxygenase | 2 | 2002 | 16 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2009 | 64 | 0.080 |
Why?
|
| Acrolein | 1 | 2008 | 23 | 0.080 |
Why?
|
| Solubility | 5 | 2006 | 227 | 0.080 |
Why?
|
| Metalloporphyrins | 2 | 2007 | 106 | 0.080 |
Why?
|
| Phospholipases A2 | 2 | 2007 | 76 | 0.080 |
Why?
|
| Lung Compliance | 4 | 2014 | 49 | 0.080 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1988 | 10 | 0.080 |
Why?
|
| Cytoplasm | 4 | 2004 | 255 | 0.080 |
Why?
|
| Autoantigens | 1 | 2011 | 399 | 0.080 |
Why?
|
| Immunoglobulins | 5 | 1981 | 148 | 0.080 |
Why?
|
| N-Formylmethionine | 4 | 1981 | 4 | 0.080 |
Why?
|
| Lipoxygenase Inhibitors | 5 | 2008 | 36 | 0.080 |
Why?
|
| Cycloheximide | 5 | 2004 | 56 | 0.080 |
Why?
|
| Phosphoproteins | 2 | 2001 | 302 | 0.080 |
Why?
|
| Keratin-18 | 1 | 2007 | 10 | 0.080 |
Why?
|
| Angiogenic Proteins | 1 | 2008 | 18 | 0.080 |
Why?
|
| Immunity, Active | 2 | 2007 | 9 | 0.080 |
Why?
|
| Estrous Cycle | 1 | 2007 | 15 | 0.080 |
Why?
|
| Cations | 2 | 1989 | 78 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 1008 | 0.080 |
Why?
|
| Hexosaminidases | 3 | 1986 | 17 | 0.080 |
Why?
|
| Protein Transport | 2 | 2013 | 400 | 0.080 |
Why?
|
| Aggressive Periodontitis | 1 | 1987 | 3 | 0.080 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2008 | 35 | 0.080 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2014 | 511 | 0.080 |
Why?
|
| Blood Bactericidal Activity | 3 | 1984 | 36 | 0.070 |
Why?
|
| Toxemia | 1 | 1987 | 5 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 8 | 2003 | 82 | 0.070 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 2 | 2004 | 12 | 0.070 |
Why?
|
| Superoxide Dismutase | 2 | 2007 | 332 | 0.070 |
Why?
|
| Guinea Pigs | 9 | 1991 | 148 | 0.070 |
Why?
|
| Pindolol | 1 | 1987 | 16 | 0.070 |
Why?
|
| Indoles | 3 | 2012 | 309 | 0.070 |
Why?
|
| Antigen-Antibody Reactions | 4 | 1971 | 49 | 0.070 |
Why?
|
| Complement Inactivator Proteins | 2 | 1987 | 40 | 0.070 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2007 | 66 | 0.070 |
Why?
|
| Secretory Vesicles | 1 | 2007 | 24 | 0.070 |
Why?
|
| Pulmonary Edema | 4 | 1986 | 116 | 0.070 |
Why?
|
| Imidazoles | 3 | 2014 | 215 | 0.070 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2007 | 45 | 0.070 |
Why?
|
| Knee Joint | 2 | 1993 | 325 | 0.070 |
Why?
|
| Amino Acid Sequence | 6 | 2003 | 2000 | 0.070 |
Why?
|
| Pulmonary Artery | 3 | 1987 | 1032 | 0.070 |
Why?
|
| Salmonella enterica | 1 | 2007 | 51 | 0.070 |
Why?
|
| Salmonella Infections | 1 | 2007 | 51 | 0.070 |
Why?
|
| Periodontal Diseases | 1 | 1987 | 58 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 526 | 0.070 |
Why?
|
| Ligands | 2 | 2006 | 568 | 0.070 |
Why?
|
| Bucladesine | 2 | 1997 | 23 | 0.070 |
Why?
|
| Ileum | 2 | 1986 | 93 | 0.070 |
Why?
|
| Autophagy | 1 | 2009 | 236 | 0.070 |
Why?
|
| Body Fluids | 1 | 1987 | 58 | 0.070 |
Why?
|
| Transfection | 4 | 2004 | 866 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2007 | 237 | 0.070 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2000 | 96 | 0.070 |
Why?
|
| Acids | 1 | 2006 | 18 | 0.070 |
Why?
|
| Acyl Coenzyme A | 1 | 2006 | 29 | 0.070 |
Why?
|
| Binding, Competitive | 4 | 2010 | 200 | 0.070 |
Why?
|
| Fetus | 1 | 1991 | 703 | 0.070 |
Why?
|
| Immune Complex Diseases | 3 | 1981 | 9 | 0.070 |
Why?
|
| Molecular Sequence Data | 6 | 2003 | 2793 | 0.070 |
Why?
|
| Autoradiography | 4 | 1988 | 71 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1987 | 133 | 0.070 |
Why?
|
| Structure-Activity Relationship | 7 | 1988 | 510 | 0.070 |
Why?
|
| Lovastatin | 1 | 2006 | 27 | 0.070 |
Why?
|
| Leukemia, Plasma Cell | 1 | 2006 | 5 | 0.070 |
Why?
|
| Rats, Inbred Strains | 8 | 1992 | 376 | 0.070 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2006 | 40 | 0.070 |
Why?
|
| Pulmonary Surfactants | 2 | 2009 | 101 | 0.070 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 2207 | 0.070 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2006 | 29 | 0.070 |
Why?
|
| Protein Phosphatase 1 | 1 | 2006 | 28 | 0.070 |
Why?
|
| Smad2 Protein | 1 | 2006 | 34 | 0.070 |
Why?
|
| Arthus Reaction | 6 | 1977 | 9 | 0.070 |
Why?
|
| Blood Proteins | 6 | 1986 | 238 | 0.070 |
Why?
|
| Microscopy, Video | 1 | 2005 | 26 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 53 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 157 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 127 | 0.060 |
Why?
|
| Membrane Potentials | 4 | 2003 | 251 | 0.060 |
Why?
|
| Poly I-C | 4 | 2014 | 52 | 0.060 |
Why?
|
| Lung Transplantation | 1 | 2007 | 246 | 0.060 |
Why?
|
| Tissue Transplantation | 1 | 2005 | 11 | 0.060 |
Why?
|
| rho-Associated Kinases | 3 | 2010 | 81 | 0.060 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2016 | 35 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2007 | 212 | 0.060 |
Why?
|
| Peroxidases | 6 | 1997 | 25 | 0.060 |
Why?
|
| Air Pollutants | 1 | 2008 | 285 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2001 | 90 | 0.060 |
Why?
|
| Substrate Specificity | 4 | 2010 | 357 | 0.060 |
Why?
|
| Heterozygote | 1 | 2005 | 254 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 215 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2007 | 296 | 0.060 |
Why?
|
| Hemocytes | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cytochromes c | 1 | 2004 | 62 | 0.060 |
Why?
|
| Fibrosis | 2 | 2005 | 455 | 0.060 |
Why?
|
| Flavonoids | 1 | 2004 | 68 | 0.060 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2004 | 66 | 0.060 |
Why?
|
| Thiazoles | 3 | 1998 | 112 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2004 | 58 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 32 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2004 | 46 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2003 | 8 | 0.060 |
Why?
|
| Receptors, CXCR4 | 1 | 2004 | 78 | 0.060 |
Why?
|
| Annexin A1 | 1 | 2003 | 2 | 0.060 |
Why?
|
| Elapid Venoms | 4 | 1987 | 15 | 0.060 |
Why?
|
| Cytosol | 4 | 1995 | 209 | 0.060 |
Why?
|
| Acute Disease | 7 | 1997 | 917 | 0.060 |
Why?
|
| Immune System Diseases | 2 | 1975 | 35 | 0.060 |
Why?
|
| Alkaline Phosphatase | 5 | 2004 | 144 | 0.060 |
Why?
|
| Eflornithine | 2 | 2001 | 7 | 0.060 |
Why?
|
| Neutralization Tests | 2 | 2002 | 62 | 0.060 |
Why?
|
| Histamine | 6 | 1994 | 65 | 0.060 |
Why?
|
| Prostaglandins E | 4 | 1988 | 46 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 522 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2001 | 352 | 0.050 |
Why?
|
| Species Specificity | 4 | 1998 | 555 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2011 | 399 | 0.050 |
Why?
|
| Phosphates | 1 | 2004 | 160 | 0.050 |
Why?
|
| Peritoneum | 2 | 2002 | 36 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 159 | 0.050 |
Why?
|
| Shock, Septic | 1 | 1985 | 184 | 0.050 |
Why?
|
| Fatty Acids, Essential | 1 | 1982 | 3 | 0.050 |
Why?
|
| Mitosporic Fungi | 1 | 1982 | 7 | 0.050 |
Why?
|
| Alternaria | 1 | 1982 | 7 | 0.050 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2003 | 104 | 0.050 |
Why?
|
| Oxidation-Reduction | 6 | 2008 | 933 | 0.050 |
Why?
|
| gamma-Globulins | 4 | 1980 | 18 | 0.050 |
Why?
|
| Antibodies, Fungal | 1 | 1982 | 9 | 0.050 |
Why?
|
| Diamide | 2 | 1993 | 4 | 0.050 |
Why?
|
| Receptors, Leukocyte-Adhesion | 2 | 1994 | 5 | 0.050 |
Why?
|
| Capillaries | 3 | 1990 | 93 | 0.050 |
Why?
|
| Acid Phosphatase | 6 | 1986 | 18 | 0.050 |
Why?
|
| Skin | 4 | 2013 | 668 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2022 | 79 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2002 | 10 | 0.050 |
Why?
|
| Proteolipids | 1 | 2002 | 28 | 0.050 |
Why?
|
| Dogs | 7 | 1992 | 344 | 0.050 |
Why?
|
| Free Radicals | 4 | 1987 | 99 | 0.050 |
Why?
|
| Transcriptome | 2 | 2019 | 742 | 0.050 |
Why?
|
| Radionuclide Imaging | 4 | 1994 | 121 | 0.050 |
Why?
|
| Inositol Phosphates | 1 | 2001 | 23 | 0.050 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2001 | 13 | 0.050 |
Why?
|
| Spermine | 1 | 2022 | 27 | 0.050 |
Why?
|
| Cell Division | 1 | 2004 | 760 | 0.050 |
Why?
|
| Spermidine | 1 | 2022 | 18 | 0.050 |
Why?
|
| Hyaluronan Receptors | 1 | 2002 | 91 | 0.050 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2001 | 24 | 0.050 |
Why?
|
| Cell Compartmentation | 2 | 1992 | 52 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2002 | 76 | 0.050 |
Why?
|
| Blood | 3 | 1989 | 97 | 0.050 |
Why?
|
| Sex Factors | 2 | 2021 | 1741 | 0.050 |
Why?
|
| Cell-Free System | 3 | 1994 | 47 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2001 | 42 | 0.050 |
Why?
|
| Polysaccharides, Bacterial | 3 | 1978 | 66 | 0.050 |
Why?
|
| Smoking | 1 | 2009 | 1468 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 205 | 0.050 |
Why?
|
| Thromboxane B2 | 3 | 1998 | 27 | 0.050 |
Why?
|
| Kallikreins | 1 | 1981 | 31 | 0.050 |
Why?
|
| Ovalbumin | 2 | 2016 | 166 | 0.050 |
Why?
|
| Hypoxia | 3 | 1991 | 937 | 0.050 |
Why?
|
| Glutathione Transferase | 2 | 2001 | 96 | 0.050 |
Why?
|
| Receptor Aggregation | 1 | 2000 | 8 | 0.050 |
Why?
|
| Immunomodulation | 1 | 2022 | 86 | 0.050 |
Why?
|
| Methionine | 1 | 1981 | 145 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 389 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1978 | 196 | 0.050 |
Why?
|
| Pregnancy | 2 | 2009 | 5556 | 0.050 |
Why?
|
| Immunoglobulin Fc Fragments | 3 | 1976 | 35 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2003 | 315 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 666 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 249 | 0.050 |
Why?
|
| Albumins | 3 | 1987 | 91 | 0.050 |
Why?
|
| Staphylococcus aureus | 2 | 2014 | 386 | 0.050 |
Why?
|
| Complement Pathway, Classical | 1 | 2000 | 19 | 0.050 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2000 | 14 | 0.050 |
Why?
|
| Lignans | 1 | 1980 | 1 | 0.050 |
Why?
|
| Neutropenia | 4 | 1987 | 127 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2001 | 102 | 0.050 |
Why?
|
| Leukosialin | 1 | 2020 | 15 | 0.050 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 14 | 0.050 |
Why?
|
| Naphthols | 1 | 1980 | 7 | 0.050 |
Why?
|
| Optical Devices | 1 | 2020 | 12 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 1998 | 477 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 62 | 0.040 |
Why?
|
| Peptide Hydrolases | 5 | 1983 | 109 | 0.040 |
Why?
|
| Platelet Factor 3 | 2 | 1977 | 2 | 0.040 |
Why?
|
| Sputum | 1 | 2002 | 291 | 0.040 |
Why?
|
| Thrombin | 4 | 1998 | 141 | 0.040 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 1 | 1999 | 6 | 0.040 |
Why?
|
| Trees | 1 | 1980 | 62 | 0.040 |
Why?
|
| Surface Properties | 2 | 1998 | 397 | 0.040 |
Why?
|
| Rosette Formation | 2 | 1993 | 16 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2000 | 160 | 0.040 |
Why?
|
| Myeloma Proteins | 4 | 1974 | 7 | 0.040 |
Why?
|
| Molecular Mimicry | 1 | 1999 | 35 | 0.040 |
Why?
|
| Airway Resistance | 2 | 1994 | 33 | 0.040 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 1999 | 38 | 0.040 |
Why?
|
| Alveolitis, Extrinsic Allergic | 2 | 1981 | 92 | 0.040 |
Why?
|
| Lipid A | 1 | 1979 | 27 | 0.040 |
Why?
|
| Complement C5a, des-Arginine | 3 | 1988 | 3 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 82 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 1999 | 106 | 0.040 |
Why?
|
| Carcinoma 256, Walker | 1 | 1979 | 1 | 0.040 |
Why?
|
| Hydroxyurea | 3 | 1995 | 30 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1987 | 313 | 0.040 |
Why?
|
| Hyaluronic Acid | 3 | 2002 | 191 | 0.040 |
Why?
|
| Hemodynamics | 3 | 1991 | 970 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2018 | 129 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 2 | 1976 | 30 | 0.040 |
Why?
|
| Receptors, Mitogen | 1 | 1998 | 8 | 0.040 |
Why?
|
| Phenotype | 4 | 2017 | 2861 | 0.040 |
Why?
|
| Escherichia coli | 5 | 1990 | 730 | 0.040 |
Why?
|
| Arginase | 1 | 2019 | 27 | 0.040 |
Why?
|
| Glutathione | 1 | 2000 | 303 | 0.040 |
Why?
|
| Peptide Fragments | 3 | 1990 | 675 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 437 | 0.040 |
Why?
|
| Allergens | 1 | 1982 | 427 | 0.040 |
Why?
|
| Brazil | 1 | 1999 | 105 | 0.040 |
Why?
|
| Helminth Proteins | 1 | 1998 | 19 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2017 | 274 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2000 | 274 | 0.040 |
Why?
|
| Fluorescence Polarization | 2 | 1988 | 35 | 0.040 |
Why?
|
| Solvents | 1 | 1999 | 109 | 0.040 |
Why?
|
| Insect Proteins | 1 | 1998 | 25 | 0.040 |
Why?
|
| Adolescent | 4 | 2020 | 17955 | 0.040 |
Why?
|
| DNA Primers | 1 | 1999 | 513 | 0.040 |
Why?
|
| Recombinant Proteins | 6 | 2003 | 1243 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2018 | 152 | 0.040 |
Why?
|
| Chemokine CXCL1 | 2 | 2011 | 66 | 0.040 |
Why?
|
| Indium Radioisotopes | 3 | 2001 | 24 | 0.040 |
Why?
|
| Tritium | 4 | 1990 | 69 | 0.040 |
Why?
|
| Binding Sites | 4 | 2010 | 1183 | 0.040 |
Why?
|
| Esters | 1 | 1998 | 61 | 0.040 |
Why?
|
| P-Selectin | 1 | 1998 | 26 | 0.040 |
Why?
|
| Prostaglandin-E Synthases | 1 | 1997 | 6 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1999 | 132 | 0.040 |
Why?
|
| Plant Leaves | 1 | 1999 | 104 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 1997 | 21 | 0.040 |
Why?
|
| Integrin alphaXbeta2 | 2 | 2006 | 2 | 0.040 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 1977 | 9 | 0.040 |
Why?
|
| Sheep | 4 | 1991 | 766 | 0.040 |
Why?
|
| Lipocalins | 1 | 1997 | 34 | 0.040 |
Why?
|
| Subcellular Fractions | 2 | 2004 | 78 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2020 | 331 | 0.040 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 1997 | 56 | 0.040 |
Why?
|
| RNA Transport | 1 | 2017 | 22 | 0.040 |
Why?
|
| Iodine Radioisotopes | 4 | 1987 | 126 | 0.040 |
Why?
|
| Passive Cutaneous Anaphylaxis | 3 | 1975 | 5 | 0.040 |
Why?
|
| Hypotension | 2 | 1976 | 116 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 1978 | 153 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 1979 | 312 | 0.040 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 3 | 1987 | 21 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 88 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1997 | 23 | 0.040 |
Why?
|
| Indomethacin | 6 | 1991 | 75 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 233 | 0.040 |
Why?
|
| RNA Interference | 2 | 2011 | 438 | 0.040 |
Why?
|
| Antibody Specificity | 2 | 1976 | 180 | 0.040 |
Why?
|
| Wound Healing | 1 | 1999 | 263 | 0.040 |
Why?
|
| Molecular Weight | 3 | 2000 | 335 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 3 | 1993 | 81 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2011 | 283 | 0.040 |
Why?
|
| Pyrrolizidine Alkaloids | 3 | 1987 | 14 | 0.040 |
Why?
|
| Bronchial Provocation Tests | 3 | 1986 | 53 | 0.030 |
Why?
|
| Chemical Phenomena | 2 | 1988 | 82 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2011 | 167 | 0.030 |
Why?
|
| Cricetinae | 2 | 2011 | 260 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 304 | 0.030 |
Why?
|
| Aerosols | 3 | 1994 | 212 | 0.030 |
Why?
|
| Receptors, Complement 3b | 2 | 1989 | 81 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1997 | 274 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2016 | 70 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1997 | 163 | 0.030 |
Why?
|
| Hydroxyproline | 2 | 2014 | 22 | 0.030 |
Why?
|
| Receptors, Interleukin-8B | 2 | 2007 | 23 | 0.030 |
Why?
|
| Thromboxane A2 | 2 | 1990 | 12 | 0.030 |
Why?
|
| Stereoisomerism | 3 | 2005 | 91 | 0.030 |
Why?
|
| Thymocytes | 1 | 2016 | 29 | 0.030 |
Why?
|
| Down-Regulation | 3 | 2006 | 605 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2009 | 351 | 0.030 |
Why?
|
| Quinolines | 1 | 1997 | 129 | 0.030 |
Why?
|
| Polymyxins | 2 | 1975 | 9 | 0.030 |
Why?
|
| Glucose | 4 | 1975 | 904 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 1984 | 153 | 0.030 |
Why?
|
| Dactinomycin | 1 | 1995 | 25 | 0.030 |
Why?
|
| Base Sequence | 1 | 1999 | 2120 | 0.030 |
Why?
|
| Immunoglobulin A | 2 | 1974 | 173 | 0.030 |
Why?
|
| Water | 1 | 1999 | 418 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 1996 | 108 | 0.030 |
Why?
|
| Mice, Inbred DBA | 2 | 1993 | 173 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 2015 | 116 | 0.030 |
Why?
|
| Permeability | 2 | 2003 | 151 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2000 | 771 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 298 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2015 | 72 | 0.030 |
Why?
|
| Asbestos | 2 | 1993 | 20 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 316 | 0.030 |
Why?
|
| Epoprostenol | 2 | 1993 | 132 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 1997 | 780 | 0.030 |
Why?
|
| Interleukin-27 | 1 | 2014 | 11 | 0.030 |
Why?
|
| Ibuprofen | 1 | 1995 | 73 | 0.030 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2014 | 26 | 0.030 |
Why?
|
| Venoms | 5 | 1975 | 30 | 0.030 |
Why?
|
| CD11b Antigen | 1 | 2014 | 58 | 0.030 |
Why?
|
| Enzyme Induction | 2 | 2002 | 85 | 0.030 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 7 | 0.030 |
Why?
|
| Radioisotopes | 3 | 1987 | 34 | 0.030 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2014 | 17 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2014 | 37 | 0.030 |
Why?
|
| Peritoneal Lavage | 1 | 1993 | 8 | 0.030 |
Why?
|
| Vacuoles | 1 | 1994 | 32 | 0.030 |
Why?
|
| Hybridomas | 2 | 2005 | 230 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2014 | 138 | 0.030 |
Why?
|
| Biological Assay | 3 | 1990 | 114 | 0.030 |
Why?
|
| Ferritins | 1 | 1994 | 57 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 147 | 0.030 |
Why?
|
| Nanoparticles | 1 | 2017 | 318 | 0.030 |
Why?
|
| Mucin 5AC | 1 | 2013 | 48 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1993 | 15 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2013 | 352 | 0.030 |
Why?
|
| Ascitic Fluid | 3 | 1985 | 15 | 0.030 |
Why?
|
| Remission Induction | 1 | 2014 | 240 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 288 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 1998 | 399 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 2749 | 0.030 |
Why?
|
| Ear, Middle | 1 | 2013 | 89 | 0.030 |
Why?
|
| Phospholipases | 2 | 1986 | 13 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2014 | 185 | 0.030 |
Why?
|
| Adenine Nucleotides | 3 | 1985 | 20 | 0.030 |
Why?
|
| Maxillary Sinusitis | 1 | 1993 | 7 | 0.030 |
Why?
|
| Liver | 4 | 2007 | 1693 | 0.030 |
Why?
|
| Blood Coagulation | 2 | 1990 | 221 | 0.030 |
Why?
|
| Vitronectin | 1 | 1992 | 4 | 0.030 |
Why?
|
| Interferons | 1 | 1994 | 152 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 1998 | 739 | 0.030 |
Why?
|
| Temperature | 3 | 1987 | 590 | 0.030 |
Why?
|
| Isoflurophate | 4 | 1976 | 6 | 0.030 |
Why?
|
| Transplantation Chimera | 2 | 2005 | 51 | 0.030 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1988 | 41 | 0.030 |
Why?
|
| Heparin | 3 | 1987 | 226 | 0.030 |
Why?
|
| Immunophenotyping | 2 | 2009 | 273 | 0.030 |
Why?
|
| Cilia | 1 | 2013 | 163 | 0.030 |
Why?
|
| Azure Stains | 1 | 1991 | 1 | 0.030 |
Why?
|
| Salmonella enteritidis | 2 | 1989 | 16 | 0.030 |
Why?
|
| Doxycycline | 1 | 2012 | 56 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2013 | 222 | 0.020 |
Why?
|
| Energy Metabolism | 4 | 1980 | 712 | 0.020 |
Why?
|
| Vasoconstriction | 4 | 1991 | 185 | 0.020 |
Why?
|
| Oxygen Consumption | 3 | 1984 | 572 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1992 | 128 | 0.020 |
Why?
|
| Sodium Channels | 1 | 1991 | 62 | 0.020 |
Why?
|
| Magnesium | 3 | 1984 | 145 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 1992 | 1226 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 5 | 1980 | 65 | 0.020 |
Why?
|
| Plastics | 2 | 1989 | 35 | 0.020 |
Why?
|
| Meclofenamic Acid | 1 | 1991 | 4 | 0.020 |
Why?
|
| Gramicidin | 1 | 1991 | 3 | 0.020 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2011 | 4 | 0.020 |
Why?
|
| Serum Sickness | 1 | 1971 | 7 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 53 | 0.020 |
Why?
|
| Potassium Channels | 1 | 1991 | 121 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2011 | 111 | 0.020 |
Why?
|
| beta-N-Acetylhexosaminidases | 2 | 1991 | 10 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2814 | 0.020 |
Why?
|
| Chromatography | 2 | 1987 | 24 | 0.020 |
Why?
|
| Docosahexaenoic Acids | 1 | 2011 | 69 | 0.020 |
Why?
|
| Adenylyl Cyclases | 1 | 2011 | 84 | 0.020 |
Why?
|
| Biological Transport | 1 | 1992 | 373 | 0.020 |
Why?
|
| Pyrroles | 1 | 2012 | 185 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 139 | 0.020 |
Why?
|
| Aging | 2 | 1999 | 1640 | 0.020 |
Why?
|
| DNA | 2 | 2010 | 1358 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 1990 | 48 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 465 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 1221 | 0.020 |
Why?
|
| Immune Adherence Reaction | 1 | 1990 | 2 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1991 | 158 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2010 | 67 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2010 | 44 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 74 | 0.020 |
Why?
|
| Caseins | 2 | 1981 | 21 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 175 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2014 | 578 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 10518 | 0.020 |
Why?
|
| Bronchial Spasm | 2 | 1986 | 7 | 0.020 |
Why?
|
| Immunization | 4 | 1984 | 402 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 2262 | 0.020 |
Why?
|
| Fibronectins | 1 | 1990 | 108 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 2 | 1980 | 24 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1989 | 532 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1990 | 100 | 0.020 |
Why?
|
| Amides | 1 | 2010 | 89 | 0.020 |
Why?
|
| Swine | 2 | 1989 | 706 | 0.020 |
Why?
|
| Fluorescent Dyes | 2 | 1988 | 302 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 447 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 2010 | 112 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 1989 | 45 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2009 | 60 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 754 | 0.020 |
Why?
|
| Phosphatidylcholines | 2 | 1987 | 134 | 0.020 |
Why?
|
| Deoxyglucose | 2 | 1982 | 43 | 0.020 |
Why?
|
| CD11c Antigen | 1 | 2009 | 38 | 0.020 |
Why?
|
| Kinins | 2 | 1983 | 3 | 0.020 |
Why?
|
| Nitrogen Mustard Compounds | 2 | 1987 | 6 | 0.020 |
Why?
|
| Zinc | 1 | 1991 | 257 | 0.020 |
Why?
|
| Diphenylhexatriene | 1 | 1988 | 1 | 0.020 |
Why?
|
| Dansyl Compounds | 1 | 1988 | 4 | 0.020 |
Why?
|
| Platelet Adhesiveness | 4 | 1973 | 15 | 0.020 |
Why?
|
| Binding Sites, Antibody | 2 | 1981 | 36 | 0.020 |
Why?
|
| O Antigens | 1 | 1988 | 8 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 1994 | 324 | 0.020 |
Why?
|
| Coombs Test | 1 | 1968 | 4 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 416 | 0.020 |
Why?
|
| Chemistry, Physical | 1 | 1988 | 40 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 1988 | 35 | 0.020 |
Why?
|
| Respiratory Function Tests | 2 | 1993 | 541 | 0.020 |
Why?
|
| Membrane Fusion | 1 | 1988 | 40 | 0.020 |
Why?
|
| Phosphatidylethanolamines | 1 | 1988 | 66 | 0.020 |
Why?
|
| Mass Spectrometry | 2 | 1998 | 661 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 724 | 0.020 |
Why?
|
| Glycerol | 1 | 1988 | 86 | 0.020 |
Why?
|
| Gene Expression | 1 | 1993 | 1442 | 0.020 |
Why?
|
| Horseradish Peroxidase | 2 | 1977 | 26 | 0.020 |
Why?
|
| Latex | 2 | 1982 | 10 | 0.020 |
Why?
|
| Agranulocytosis | 2 | 1986 | 31 | 0.020 |
Why?
|
| Eicosanoic Acids | 1 | 1987 | 4 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1987 | 17 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 1987 | 91 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 1988 | 112 | 0.020 |
Why?
|
| Immunoelectrophoresis | 3 | 1980 | 6 | 0.020 |
Why?
|
| Indium | 1 | 1987 | 10 | 0.020 |
Why?
|
| Viscosity | 1 | 1987 | 82 | 0.020 |
Why?
|
| Iodocyanopindolol | 1 | 1987 | 12 | 0.020 |
Why?
|
| Microspheres | 2 | 1982 | 123 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2007 | 14 | 0.020 |
Why?
|
| Interferon Type I | 1 | 1988 | 129 | 0.020 |
Why?
|
| Centrifugation | 1 | 1987 | 31 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2008 | 347 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2009 | 304 | 0.020 |
Why?
|
| Propranolol | 1 | 1987 | 53 | 0.020 |
Why?
|
| Lipoxygenase | 3 | 1998 | 12 | 0.020 |
Why?
|
| Complement C3-C5 Convertases | 1 | 1987 | 19 | 0.020 |
Why?
|
| Complement Factor B | 3 | 1994 | 100 | 0.020 |
Why?
|
| Survival Rate | 1 | 2011 | 1653 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1988 | 169 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2007 | 66 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 664 | 0.020 |
Why?
|
| Cell Death | 1 | 2008 | 324 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1987 | 128 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 339 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 425 | 0.020 |
Why?
|
| Alprazolam | 1 | 1986 | 6 | 0.020 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2006 | 10 | 0.020 |
Why?
|
| Blood Pressure | 6 | 1990 | 1536 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2011 | 644 | 0.020 |
Why?
|
| Mannans | 1 | 1986 | 4 | 0.020 |
Why?
|
| Photomicrography | 1 | 2006 | 7 | 0.020 |
Why?
|
| Membranes | 2 | 1977 | 18 | 0.020 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2006 | 11 | 0.020 |
Why?
|
| Metalloproteases | 1 | 2006 | 37 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2006 | 40 | 0.020 |
Why?
|
| Desensitization, Immunologic | 2 | 1980 | 117 | 0.020 |
Why?
|
| Protein Prenylation | 1 | 2006 | 20 | 0.020 |
Why?
|
| Glomerulonephritis | 3 | 1971 | 45 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2006 | 1602 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2006 | 77 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 3 | 1992 | 37 | 0.020 |
Why?
|
| Goats | 2 | 1980 | 26 | 0.020 |
Why?
|
| Self Tolerance | 1 | 2006 | 28 | 0.020 |
Why?
|
| Thromboxanes | 2 | 1991 | 16 | 0.020 |
Why?
|
| Complement C6 | 2 | 1976 | 9 | 0.020 |
Why?
|
| Angiotensin II | 1 | 1986 | 91 | 0.020 |
Why?
|
| Mannose-Binding Lectin | 1 | 2006 | 21 | 0.020 |
Why?
|
| Thermodynamics | 1 | 1988 | 382 | 0.020 |
Why?
|
| Methylamines | 1 | 1986 | 30 | 0.020 |
Why?
|
| Receptors, Fc | 2 | 1989 | 45 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2006 | 93 | 0.020 |
Why?
|
| Edetic Acid | 2 | 1980 | 45 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1986 | 137 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2009 | 679 | 0.020 |
Why?
|
| Ammonium Chloride | 1 | 1985 | 4 | 0.020 |
Why?
|
| Ficoll | 1 | 1985 | 5 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 1392 | 0.020 |
Why?
|
| Blood Physiological Phenomena | 1 | 1985 | 14 | 0.020 |
Why?
|
| Graft Survival | 1 | 2007 | 481 | 0.020 |
Why?
|
| Acetylcholine | 1 | 1986 | 180 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 3 | 1992 | 403 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 1985 | 69 | 0.020 |
Why?
|
| Germinal Center | 1 | 2005 | 46 | 0.020 |
Why?
|
| Trypsin | 2 | 1979 | 67 | 0.020 |
Why?
|
| Ecdysterone | 1 | 2004 | 3 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 1985 | 60 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2005 | 137 | 0.020 |
Why?
|
| Receptors, Scavenger | 1 | 2004 | 16 | 0.020 |
Why?
|
| Chemistry | 1 | 1984 | 39 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2005 | 137 | 0.020 |
Why?
|
| Serum Albumin, Radio-Iodinated | 4 | 1972 | 6 | 0.020 |
Why?
|
| Ischemia | 1 | 2007 | 363 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2004 | 44 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1984 | 43 | 0.010 |
Why?
|
| Lactoferrin | 2 | 1984 | 28 | 0.010 |
Why?
|
| Factor Va | 1 | 2004 | 3 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2004 | 22 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 2004 | 28 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 286 | 0.010 |
Why?
|
| Age Factors | 1 | 2011 | 2912 | 0.010 |
Why?
|
| Phosphorylcholine | 1 | 2004 | 18 | 0.010 |
Why?
|
| Computer Simulation | 1 | 1988 | 887 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1984 | 128 | 0.010 |
Why?
|
| Detergents | 1 | 2004 | 41 | 0.010 |
Why?
|
| Senecio | 1 | 1983 | 4 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2004 | 37 | 0.010 |
Why?
|
| Perfusion | 3 | 1992 | 152 | 0.010 |
Why?
|
| Nephritis | 2 | 1975 | 19 | 0.010 |
Why?
|
| Chemokine CXCL12 | 1 | 2004 | 75 | 0.010 |
Why?
|
| Plants, Toxic | 1 | 1983 | 28 | 0.010 |
Why?
|
| Interleukin-1 | 3 | 1994 | 971 | 0.010 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 2 | 1974 | 9 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2005 | 170 | 0.010 |
Why?
|
| Cell Aggregation | 2 | 1974 | 24 | 0.010 |
Why?
|
| Glycolysis | 2 | 1975 | 222 | 0.010 |
Why?
|
| Snakes | 2 | 1975 | 20 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1984 | 121 | 0.010 |
Why?
|
| Macroglobulins | 2 | 1973 | 2 | 0.010 |
Why?
|
| Lymphokines | 1 | 1983 | 115 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 2 | 1985 | 1752 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 1977 | 54 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 1974 | 69 | 0.010 |
Why?
|
| Micropore Filters | 2 | 1973 | 6 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2003 | 173 | 0.010 |
Why?
|
| Blood Cell Count | 2 | 1990 | 52 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1986 | 230 | 0.010 |
Why?
|
| DNA Replication | 1 | 1984 | 204 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2003 | 115 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1984 | 268 | 0.010 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 1987 | 330 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1982 | 108 | 0.010 |
Why?
|
| Capillary Resistance | 1 | 1982 | 5 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1987 | 545 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 383 | 0.010 |
Why?
|
| Hyperemia | 1 | 1983 | 44 | 0.010 |
Why?
|
| Secretory Rate | 2 | 1985 | 16 | 0.010 |
Why?
|
| Immunodiffusion | 2 | 1972 | 9 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 374 | 0.010 |
Why?
|
| Chimera | 1 | 2002 | 59 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1986 | 476 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 694 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 52 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 2001 | 12 | 0.010 |
Why?
|
| Iodine Isotopes | 2 | 1972 | 5 | 0.010 |
Why?
|
| Lysine Carboxypeptidase | 1 | 1981 | 1 | 0.010 |
Why?
|
| Respiratory Tract Infections | 2 | 1982 | 323 | 0.010 |
Why?
|
| Factor XII | 1 | 1981 | 5 | 0.010 |
Why?
|
| Monocrotaline | 3 | 1987 | 33 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 176 | 0.010 |
Why?
|
| Arginine | 1 | 1982 | 241 | 0.010 |
Why?
|
| Diazonium Compounds | 1 | 1981 | 1 | 0.010 |
Why?
|
| Sulfanilic Acids | 1 | 1981 | 1 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 198 | 0.010 |
Why?
|
| Theophylline | 2 | 1985 | 60 | 0.010 |
Why?
|
| Benzenesulfonates | 1 | 1981 | 21 | 0.010 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1981 | 18 | 0.010 |
Why?
|
| Anions | 1 | 1981 | 31 | 0.010 |
Why?
|
| Staphylococcal Protein A | 1 | 1980 | 9 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 2001 | 20 | 0.010 |
Why?
|
| Arteritis | 2 | 1971 | 27 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 616 | 0.010 |
Why?
|
| Hemorrhage | 2 | 1982 | 616 | 0.010 |
Why?
|
| Nucleotidases | 1 | 1980 | 7 | 0.010 |
Why?
|
| Adenosine Diphosphate | 2 | 1979 | 81 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 346 | 0.010 |
Why?
|
| Tuberculosis | 1 | 1983 | 243 | 0.010 |
Why?
|
| Rubidium | 2 | 1970 | 12 | 0.010 |
Why?
|
| Calcitriol | 1 | 2001 | 53 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1992 | 1724 | 0.010 |
Why?
|
| Amino Acids | 2 | 1989 | 455 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1980 | 44 | 0.010 |
Why?
|
| CHO Cells | 1 | 2000 | 140 | 0.010 |
Why?
|
| Salmonella | 2 | 1978 | 54 | 0.010 |
Why?
|
| Carboxylic Acids | 1 | 1980 | 26 | 0.010 |
Why?
|
| Particle Size | 1 | 1981 | 341 | 0.010 |
Why?
|
| Organ Size | 1 | 1981 | 435 | 0.010 |
Why?
|
| Organoids | 1 | 1980 | 75 | 0.010 |
Why?
|
| Amines | 2 | 1970 | 38 | 0.010 |
Why?
|
| Risk Factors | 2 | 1992 | 8714 | 0.010 |
Why?
|
| Mycobacterium bovis | 1 | 1979 | 11 | 0.010 |
Why?
|
| Snake Venoms | 2 | 1976 | 18 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1980 | 58 | 0.010 |
Why?
|
| Protein Kinase C-delta | 1 | 2000 | 70 | 0.010 |
Why?
|
| Nucleotides | 2 | 1970 | 113 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2006 | 6267 | 0.010 |
Why?
|
| Leukemia L1210 | 1 | 1999 | 7 | 0.010 |
Why?
|
| Fluoresceins | 2 | 1991 | 46 | 0.010 |
Why?
|
| Mercaptoethanol | 2 | 1970 | 11 | 0.010 |
Why?
|
| Thiocyanates | 2 | 1991 | 29 | 0.010 |
Why?
|
| Aminopyridines | 1 | 2000 | 81 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 1979 | 28 | 0.010 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 1999 | 4 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1982 | 554 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2000 | 298 | 0.010 |
Why?
|
| Superantigens | 1 | 1999 | 69 | 0.010 |
Why?
|
| Manganese | 1 | 1999 | 52 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1999 | 83 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 301 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 850 | 0.010 |
Why?
|
| Phenols | 1 | 1979 | 84 | 0.010 |
Why?
|
| Prostaglandin Endoperoxides | 1 | 1978 | 1 | 0.010 |
Why?
|
| Prostaglandins G | 1 | 1978 | 1 | 0.010 |
Why?
|
| Prostaglandins H | 1 | 1978 | 2 | 0.010 |
Why?
|
| Glycols | 1 | 1998 | 4 | 0.010 |
Why?
|
| Prostaglandins F | 1 | 1978 | 17 | 0.010 |
Why?
|
| Fatty Alcohols | 1 | 1998 | 5 | 0.010 |
Why?
|
| Hexosephosphates | 2 | 1975 | 4 | 0.010 |
Why?
|
| tert-Butylhydroperoxide | 1 | 1998 | 10 | 0.010 |
Why?
|
| Phosphatidic Acids | 1 | 1998 | 9 | 0.010 |
Why?
|
| Isomerism | 1 | 1998 | 42 | 0.010 |
Why?
|
| Peroxides | 1 | 1998 | 20 | 0.010 |
Why?
|
| Acetophenones | 1 | 1978 | 14 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 1982 | 338 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 1991 | 72 | 0.010 |
Why?
|
| Caspases | 1 | 1999 | 245 | 0.010 |
Why?
|
| Uric Acid | 1 | 1979 | 150 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2000 | 215 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 1979 | 244 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 1977 | 36 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1977 | 72 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 1997 | 30 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2001 | 1149 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 1976 | 57 | 0.010 |
Why?
|
| Child | 1 | 2015 | 18555 | 0.010 |
Why?
|
| Sepsis | 1 | 1982 | 519 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 2 | 1972 | 14 | 0.010 |
Why?
|
| Complement C7 | 1 | 1976 | 1 | 0.010 |
Why?
|
| Receptors, Concanavalin A | 1 | 1976 | 2 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 1976 | 12 | 0.010 |
Why?
|
| Contractile Proteins | 1 | 1976 | 16 | 0.010 |
Why?
|
| Organophosphonates | 1 | 1976 | 91 | 0.010 |
Why?
|
| Pentosephosphates | 1 | 1975 | 1 | 0.010 |
Why?
|
| Complement C4 | 1 | 1976 | 26 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1975 | 23 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1977 | 175 | 0.010 |
Why?
|
| Colchicine | 1 | 1975 | 24 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1975 | 57 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1975 | 52 | 0.010 |
Why?
|
| Nitrobenzenes | 1 | 1975 | 13 | 0.010 |
Why?
|
| Sulfonic Acids | 1 | 1975 | 12 | 0.010 |
Why?
|
| Immunization, Passive | 2 | 1985 | 79 | 0.010 |
Why?
|
| Sepharose | 1 | 1975 | 33 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 1994 | 20 | 0.010 |
Why?
|
| Fucose | 1 | 1994 | 3 | 0.010 |
Why?
|
| Mannose | 1 | 1994 | 21 | 0.010 |
Why?
|
| Hemolysis | 1 | 1976 | 146 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1994 | 50 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1976 | 177 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1994 | 178 | 0.010 |
Why?
|
| Filtration | 2 | 1990 | 61 | 0.010 |
Why?
|
| Phagocyte Bactericidal Dysfunction | 1 | 1974 | 12 | 0.010 |
Why?
|
| Polysaccharides | 1 | 1994 | 79 | 0.010 |
Why?
|
| Abdominal Muscles | 1 | 1994 | 6 | 0.010 |
Why?
|
| Genotype | 1 | 1999 | 1842 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1974 | 18 | 0.010 |
Why?
|
| Immunoglobulin Fragments | 1 | 1974 | 15 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1989 | 1004 | 0.010 |
Why?
|
| Cell Size | 1 | 1994 | 81 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1994 | 374 | 0.010 |
Why?
|
| Epitopes | 1 | 1975 | 438 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1994 | 140 | 0.010 |
Why?
|
| Microtubules | 1 | 1976 | 238 | 0.010 |
Why?
|
| Maxillary Sinus | 1 | 1993 | 11 | 0.010 |
Why?
|
| Leukocidins | 1 | 1973 | 2 | 0.010 |
Why?
|
| Venules | 1 | 1993 | 13 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 3371 | 0.010 |
Why?
|
| Tetanus Antitoxin | 1 | 1972 | 3 | 0.010 |
Why?
|
| NADP | 2 | 1984 | 42 | 0.010 |
Why?
|
| Interferon-beta | 1 | 1993 | 80 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 1973 | 50 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1994 | 264 | 0.010 |
Why?
|
| Tetanus Toxoid | 1 | 1972 | 37 | 0.010 |
Why?
|
| Arterioles | 1 | 1993 | 40 | 0.010 |
Why?
|
| Synovial Fluid | 2 | 1989 | 57 | 0.010 |
Why?
|
| Immunoradiometric Assay | 1 | 1992 | 2 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1972 | 72 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1992 | 47 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1972 | 36 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1992 | 163 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 193 | 0.010 |
Why?
|
| Galactosidases | 1 | 1971 | 2 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1993 | 161 | 0.010 |
Why?
|
| Posture | 1 | 1993 | 150 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1971 | 50 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1971 | 29 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1973 | 302 | 0.010 |
Why?
|
| 5,8,11,14-Eicosatetraynoic Acid | 1 | 1991 | 3 | 0.010 |
Why?
|
| Asbestos, Serpentine | 1 | 1991 | 4 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 9166 | 0.010 |
Why?
|
| Proteinuria | 1 | 1971 | 78 | 0.010 |
Why?
|
| Edema | 2 | 1983 | 119 | 0.010 |
Why?
|
| Kidney | 1 | 1977 | 1208 | 0.010 |
Why?
|
| Benzoquinones | 1 | 1991 | 44 | 0.010 |
Why?
|
| Histamine H1 Antagonists | 1 | 1970 | 33 | 0.010 |
Why?
|
| Nucleosides | 1 | 1970 | 25 | 0.010 |
Why?
|
| Hemagglutination | 1 | 1970 | 7 | 0.010 |
Why?
|
| Feedback | 1 | 1991 | 149 | 0.010 |
Why?
|
| Thoracic Duct | 1 | 1970 | 3 | 0.010 |
Why?
|
| Absorption | 1 | 1970 | 53 | 0.010 |
Why?
|
| Pepsin A | 1 | 1970 | 18 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1970 | 23 | 0.010 |
Why?
|
| Fixatives | 1 | 1989 | 16 | 0.010 |
Why?
|
| Hirudins | 1 | 1970 | 46 | 0.010 |
Why?
|
| Glutaral | 1 | 1989 | 15 | 0.010 |
Why?
|
| Acetylglucosamine | 1 | 1989 | 10 | 0.010 |
Why?
|
| Amino Sugars | 1 | 1989 | 8 | 0.010 |
Why?
|
| Surface-Active Agents | 1 | 1970 | 79 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1989 | 58 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1992 | 961 | 0.010 |
Why?
|
| Lymph | 1 | 1970 | 40 | 0.010 |
Why?
|
| Vena Cava, Inferior | 1 | 1990 | 55 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1990 | 172 | 0.010 |
Why?
|
| Glycosylation | 1 | 1989 | 133 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 1971 | 165 | 0.010 |
Why?
|
| Methysergide | 1 | 1969 | 1 | 0.010 |
Why?
|
| Immunity | 1 | 1970 | 124 | 0.010 |
Why?
|
| Chlorpheniramine | 1 | 1969 | 9 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1991 | 414 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1969 | 25 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 1969 | 30 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1970 | 273 | 0.010 |
Why?
|
| Haplorhini | 1 | 1969 | 59 | 0.010 |
Why?
|
| Epinephrine | 1 | 1990 | 166 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1990 | 324 | 0.000 |
Why?
|
| Horses | 1 | 1969 | 97 | 0.000 |
Why?
|
| Cats | 1 | 1969 | 205 | 0.000 |
Why?
|
| Immunochemistry | 1 | 1968 | 11 | 0.000 |
Why?
|
| Trypanosomiasis | 1 | 1968 | 5 | 0.000 |
Why?
|
| Haptens | 1 | 1968 | 21 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1970 | 230 | 0.000 |
Why?
|
| Prostaglandins D | 1 | 1988 | 2 | 0.000 |
Why?
|
| Carboxypeptidases | 1 | 1988 | 14 | 0.000 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 1968 | 18 | 0.000 |
Why?
|
| Staphylococcus | 1 | 1968 | 69 | 0.000 |
Why?
|
| Aspirin | 1 | 1970 | 326 | 0.000 |
Why?
|
| Glycerylphosphorylcholine | 1 | 1987 | 5 | 0.000 |
Why?
|
| Quinolinium Compounds | 1 | 1987 | 2 | 0.000 |
Why?
|
| Thrombin Time | 1 | 1987 | 11 | 0.000 |
Why?
|
| Vinblastine | 1 | 1987 | 61 | 0.000 |
Why?
|
| Partial Thromboplastin Time | 1 | 1987 | 51 | 0.000 |
Why?
|
| Osteoarthritis | 1 | 1989 | 173 | 0.000 |
Why?
|
| Salmonella typhimurium | 1 | 1968 | 161 | 0.000 |
Why?
|
| Pollen | 1 | 1986 | 25 | 0.000 |
Why?
|
| Tosyllysine Chloromethyl Ketone | 1 | 1986 | 1 | 0.000 |
Why?
|
| Microbial Collagenase | 1 | 1986 | 10 | 0.000 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1986 | 22 | 0.000 |
Why?
|
| Hydrolysis | 1 | 1986 | 179 | 0.000 |
Why?
|
| Thiourea | 1 | 1986 | 39 | 0.000 |
Why?
|
| Mechlorethamine | 1 | 1986 | 64 | 0.000 |
Why?
|
| Arachidonate Lipoxygenases | 1 | 1985 | 2 | 0.000 |
Why?
|
| Diethylcarbamazine | 1 | 1985 | 5 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1985 | 45 | 0.000 |
Why?
|
| Tubercidin | 1 | 1985 | 1 | 0.000 |
Why?
|
| Glucose Oxidase | 1 | 1985 | 18 | 0.000 |
Why?
|
| Chromatin | 1 | 1989 | 427 | 0.000 |
Why?
|
| Infant, Newborn | 2 | 1987 | 5089 | 0.000 |
Why?
|
| Receptors, Purinergic | 1 | 1985 | 20 | 0.000 |
Why?
|
| Catalase | 1 | 1985 | 118 | 0.000 |
Why?
|
| Arteries | 1 | 1987 | 249 | 0.000 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1986 | 110 | 0.000 |
Why?
|
| Homocysteine | 1 | 1985 | 135 | 0.000 |
Why?
|
| Carbon Radioisotopes | 2 | 1974 | 39 | 0.000 |
Why?
|
| Mice, Mutant Strains | 1 | 1984 | 271 | 0.000 |
Why?
|
| Complement Fixation Tests | 1 | 1983 | 6 | 0.000 |
Why?
|
| Foam Cells | 1 | 1983 | 13 | 0.000 |
Why?
|
| Macrophage-Activating Factors | 1 | 1983 | 4 | 0.000 |
Why?
|
| Bufo marinus | 1 | 1983 | 4 | 0.000 |
Why?
|
| Adenosine | 1 | 1985 | 204 | 0.000 |
Why?
|
| Adenine | 1 | 1985 | 221 | 0.000 |
Why?
|
| Cell Membrane Permeability | 1 | 1983 | 83 | 0.000 |
Why?
|
| Ion Channels | 1 | 1983 | 123 | 0.000 |
Why?
|
| Interleukin-2 | 1 | 1983 | 414 | 0.000 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 1981 | 4 | 0.000 |
Why?
|
| Bacteria | 1 | 1968 | 731 | 0.000 |
Why?
|
| Synovial Membrane | 2 | 1972 | 74 | 0.000 |
Why?
|
| Pulmonary Eosinophilia | 1 | 1981 | 27 | 0.000 |
Why?
|
| Concanavalin A | 1 | 1981 | 75 | 0.000 |
Why?
|
| Fluorides | 1 | 1981 | 45 | 0.000 |
Why?
|
| Rheumatoid Factor | 1 | 1981 | 157 | 0.000 |
Why?
|
| Sarcoidosis | 1 | 1981 | 133 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1980 | 194 | 0.000 |
Why?
|
| Fibrin | 1 | 1980 | 65 | 0.000 |
Why?
|
| Serratia marcescens | 1 | 1975 | 12 | 0.000 |
Why?
|
| Tissue Extracts | 1 | 1974 | 20 | 0.000 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1972 | 22 | 0.000 |
Why?
|
| Knee | 1 | 1972 | 50 | 0.000 |
Why?
|
| Hindlimb | 1 | 1972 | 125 | 0.000 |
Why?
|
| Joints | 1 | 1972 | 84 | 0.000 |
Why?
|